Evidence map›Paper›PMID 35661927›Full record

ArticleCellular and molecular life sciences : CMLS2022

Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells.

Matthias Rath, Konrad Schwefel, Matteo Malinverno, Dariush Skowronek, Alexandra Leopoldi, Robin A Pilz, Doreen Biedenweg, Sander Bekeschus, Josef M Penninger, Elisabetta Dejana and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Endothelial Differentiation ofInternational journal of molecular sciences · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Matthias Rath *Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, 17475, Greifswald, Germany. matthias.rath@med.uni-greifswald.de.ORCID http://orcid.org/0000-0002-7834-4650
Konrad Schwefel *Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, 17475, Greifswald, Germany.
Matteo MalinvernoVascular Biology Unit, FIRC Institute of Molecular Oncology Foundation (IFOM), Milan, Italy.
Dariush SkowronekDepartment of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, 17475, Greifswald, Germany.
Alexandra LeopoldiInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Robin A PilzDepartment of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, 17475, Greifswald, Germany.
Doreen BiedenwegCentre for Innovation Competence-Humoral Immune Reactions in Cardiovascular Diseases, University of Greifswald, Greifswald, Germany.
Sander BekeschusZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Greifswald, Germany.
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Elisabetta DejanaVascular Biology Unit, FIRC Institute of Molecular Oncology Foundation (IFOM), Milan, Italy.
Ute FelborDepartment of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, 17475, Greifswald, Germany.
Universitätsmedizin Greifswald · DEInstitute of Molecular Biotechnology · ATIFOM · ITLeibniz Institute for Plasma Science and Technology · DEUppsala University · SE

Funding

Bundesministerium für Bildung und Forschung 03Z22CN11Bundesministerium für Bildung und Forschung 03Z22Di1Bundesministerium für Bildung und Forschung 03Z22DN11Bundesministerium für Bildung und Forschung 161L0276Deutsche Forschungsgemeinschaft RA2876/2-2Research Network Molecular Medicine of the University Medicine Greifswald FOVB-2020-01Research Network Molecular Medicine of the University Medicine Greifswald FOVB-2021-07
6 · The paper itself

Abstract

Cerebral cavernous malformations (CCM) are low-flow vascular lesions prone to cause severe hemorrhage-associated neurological complications. Pathogenic germline variants in CCM1, CCM2, or CCM3 can be identified in nearly 100% of CCM patients with a positive family history. In line with the concept that tumor-like mechanisms are involved in CCM formation and growth, we here demonstrate an abnormally increased proliferation rate of CCM3-deficient endothelial cells in co-culture with wild-type cells and in mosaic human iPSC-derived vascular organoids. The observation that NSC59984, an anticancer drug, blocked the abnormal proliferation of mutant endothelial cells further supports this intriguing concept. Fluorescence-activated cell sorting and RNA sequencing revealed that co-culture induces upregulation of proangiogenic chemokine genes in wild-type endothelial cells. Furthermore, genes known to be significantly downregulated in CCM3

Indexed as

Endothelial CellsHemangioma, Cavernous, Central Nervous SystemApoptosis Regulatory ProteinsCell ProliferationCoculture TechniquesHumansProto-Oncogene ProteinsApoptosis Regulatory ProteinsProto-Oncogene ProteinsCerebral cavernous malformationsCo-cultureCRISPR/Cas9 genome editingNSC59984RNA sequencingTumor-like behavior

Identifiers

PMID35661927
PMCPMC9166869
OpenAlexW4281920588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.